Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Aratana gets conditional approval for AT-005, a treatment for T-cell lymphoma in dogs
Aratana gets conditional approval for AT-005, a treatment for T-cell lymphoma in dogs
Aratana gets conditional approval for AT-005, a treatment for T-cell lymphoma in dogs
Submitted by
admin
on January 28, 2014 - 11:16am
Source:
Yahoo/AP
News Tags:
Aratana
AT-005
animal health
Headline:
Aratana gets conditional approval for AT-005, a treatment for T-cell lymphoma in dogs
Do Not Allow Advertisers to Use My Personal information
